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Marine sediment samples from Machilipatnam (Krishna District, A.P) coast off Bay of Bengal, India were 
investigated as a source of actinomycetes to screen for the production of novel bioactive compounds. 
More than 10,000 bioactive compounds have been described from marine actinomycetes, with many 
different properties, ranging from colour pigments to cytotoxic compounds. The search for cytotoxic 
compounds is continuing due to the demand for new anticancer drugs. In this work, compound I was 
isolated from the marine derived actinomycete strain AUBN10/2, obtained from marine sediment samples 
of Bay of Bengal, India. This was obtained by solvent extraction followed by chromatographic 
purification. The pure compound I was identified from spectroscopic data which was related to the 
actinomycin D, it showed a potent cytotoxic activity against cell lines HMO2 (gastric adenocarcinoma) 
and HePG2 (hepatic carcinoma) in vitro. It also exhibited antimicrobial activities against gram positive 
and negative bacteria.  
 






Actinomycetes are prolific producers of antibiotics and 
majority of the antibiotics in clinical use today are pro-
duced by them. Among the various microorganisms, the 
actinomycetes have yielded over two-third of the naturally 
occurring antibiotics and continued to be a major source 
of novel and useful antibiotics. Apart from antibiotics, 
actinomycetes also produce other bioactive secondary 
metabolites (Bérdy, 2005), anticancer (mitomycin and 
daunomycin) (Galm et al., 2005) and immunosuppressive 
agents (rapamycin and FK506) (Simmons et al., 2005). 
Although these organisms are continually studied exten-
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Abbreviations: GI50, Drug concentration causing 50% growth 
inhibition; LC50, minimum concentration which reduces the initial 
cell number to half; TGI, drug concentration causing 100% 
growth inhibition; MIC, minimum inhibitory concentrations; I, 
purified antibiotic. 
bolites from terrestrial actinomycetes is decreasing and 
that new source of bioactive substances must be 
explored (Fenical and Jensen, 2006). One of such resou-
rce can be found in marine microorganisms, which are 
now being explored for their potential as producers of bio-
medically important metabolites (Krasil’nikov, 1962; 
Okami et al., 1976 Pisano et al., 1986; Weyland and 
Helmke, 1988; Williams et al., 1999). In this study, we 
reported the extraction, purification and structure elucida-
tion of cytotoxic compound I, which can be considered as 
a new source of cytotoxic antibiotic from the marine-
derived actinomycete strain AUBN10/2, isolated from the 
marine sediment samples of Bay of Bengal, India. 
 
 
MATERIALS AND METHODS 
 
Isolation and maintenance 
 
Strain AUB N10/2 was isolated from a marine sediment sample 
colleted at a depth of 30 m at a distance of 8 km  off  Machilipatnam  




coast of Bay of Bengal. For the isolation, starch casein agar with 
the addition of rifampicin (Pisano et al., 1989) (2.5 µg/ml) and 
flucanozole (75 µg/ml) was used to minimize bacterial and fungal 
contaminations, respectively. The strain was sub-cultured onto 
starch casein agar  slant (medium with 50% sea water) (Weyland, 
1981), incubated at 28°C for 5 - 7 days to achieve good sporulation 





Taxonomic characteristics of the isolate were determined by 
cultivation on various media as described by Shirling and Gottlieb 
(1966), and Waksman (1961) and Arai (1975). Morphological 
characteristics were observed after incubation of the culture at 28°C 
for 14 days on Oatmeal agar (ISP med 3). Cultural characteristics 
were determined after growing the culture at 28°C for 14 days. The 
carbon source utilization pattern was determined as per the ISP 
protocol (Shirling and Gottlieb, 1966). Cell wall composition was 
analysed by the method of Lechevalier and Lechevalier (1975), 
using thin layer chromatography plates as described by Staneck 





A full grown slant culture of the strain AUBN10/2 on starch casein 
agar (composition: 1.0% soluble starch, 0.03% Casein, 0.2% KNO3, 
0.2% NaCl, 0.005% K2HPO4, 0.002% CaCO3, 0.001% FeSO4.7H2O 
and 2.0% agar) was transferred into Erlenmeyer flasks (2 x 250 ml) 
containing 50 ml of seed medium (composition: 1.0% Soyabean 
meal, 1.0% corn steep solids, 0.5% glucose and 0.5% CaCO3 with 
pH 7.0) and incubated for 3 days at 28°C on a rotary shaker (220 
rpm). A 10% level of this inoculum was transferred into 200 ml of 
production medium in 1 L EM flasks (30 No’s). The medium com-
position is: 1.0% soyabean meal, 0.5% corn steep solids, 1.0% 
soluble starch, 0.5% glucose and 0.7% calcium carbonate with pH 
7.0. The inoculated production flasks were incubated for 72 h at 
28°C on a rotary shaker (220 rpm).  
The culture broth (6.5 L) was centrifuged at 4000 rpm for 10 min, 
at 10°C and clear culture supernatant was separated. It was 
extracted twice with ethyl acetate (2 x 1.2 L) and washed with 500 
ml water at pH
 
7.0. The ethyl acetate layer was concentrated in 
vacuum at 35°C to give 5.0 g of the crude ethyl acetate extract.  A 
polymer was obtained from the crude ethyl acetate extract, which 
did not possess any antimicrobial activity.
 
The mycelium was 
extracted with acetone (1.0 L) and then centrifuged (4000 rpm, 10 
min and 10°C). The acetone extract was concentrated in vacuum 
and lyophilized to obtain 4.5 g of mycelium extract. 
The mycelium extract (5.0 g) was chromatographed on a silica 
gel column (22 X 5 cm) and eluted with dichloromethane/methanol 
(95:5, 1 L) to give ten fractions (Figure 1). The dried residues of all 
10 fractions were dissolved, each in a specified volume of dichlo-
romethane to give 1 mg/ml concentration and tested for their 
antimicrobial activities using Bacillus subtilis as test organism by 
disc-plate method. Among 10 fractions, fraction VI (41.8 mg) 
exhibited good activity and was purified by chromatography on 
Sephadex LH-20 (methanol) to obtain four fractions. The third 
fraction VIc was found to possess good antimicrobial activity while 
others have no or negligible activities. The active fraction VIc was 
further purified by chromatography on Sephadex LH-20 (acetone) 
resulting in two distinct fractions VIc.I (6.8 mg) and VIc.II (5.5 mg). 
Fraction VIc.I (1) had good antimicrobial activity (100 µg/ml) but 
negligible activity was observed with VIc.II. Compound 1 (Figure 2) 
was found to be pure and was pale yellow solid, which was 
identified as actinomycin D (Inbar and Lapidot, 1988). 










and ESI mass spectra. 
 
  
Instrumental analysis  
 
Melting points were determined on a Fisher-Johns apparatus. NMR 
experiments were performed on Bruker DRX-500 (500 MHZ) and 
Bruker AMX 300 (300 MHZ). The chemical shifts were expressed in 
δ (ppm) using CDCl3 as solvent and TMS as internal reference. The 
MS spectra were measured on Varian MAT 731 and Finnigan MAT 
311 A. UV spectra were recorded on a Kontron Uvikon 860. IR 
spectrum was measured on a Perkin Elmer Model 298 (KBr discs). 
TLC was carried out on silica gel 60 F254 plates (Merck, 0.25 mm) 
and column chromatography on silica gel (Macherey and Nagel, < 
0.08 mm) or Sephadex LH-20 (Pharmacia). Rf values were 
determined on 20 x 20 cm plates, the evaluation length was 10 cm. 
Compounds were viewed under UV lamp at 254 nm and sprayed 
with anisaldehyde-H2SO4 followed by heating.   
 
 
Cytotoxic activity  
 
The cytotoxic activity of the pure compound was performed on the 
growth of tumor cells in vitro for their cytotoxic or cytostatic 
activities, according to the NCI guide lines (Grever et al., 1992). The 
cell lines used were HMO2 (Gastric adenocarcinoma) and HePG2 
(Hepatic carcinoma). Cells were grown in 96-well microtitre plates 
of RPMI 1640 tissue culture medium supplemented with 10% fetal 
calf serum at 37°C in a humified atmosphere of 50% CO2 in air. 
After 24 h of incubation, the pure compounds (0.1 ~ 10.0 µg/ml) 
were added to the cells. After 48 h incubation, the cells were fixed 
by addition of trichloracetic acid and cell protein was assayed with 
sulforhodamine B (Skehan et al., 1990). For compound I tested, the 
GI50 (drug concentration causing 50% growth inhibition), TGI values 
(drug concentration causing 100% growth inhibition) and LC50 
(minimum concentration which reduces the initial cell number to 





The minimum inhibitory concentrations (MIC) of the purified 
antibiotic (I) against different test organisms were determined by the 
broth dilution method (Table 3). 
 
 
RESULTS AND DISCUSSION 
 
Taxonomy of strain production 
 
The sporophores occurred as short closed spirals with 2 
to 4 turns, arranged in groups and formed spiral spore 
chains which belong to section Spira (S). The cultural 
characteristics of the strain are summarized in Table 1. 
The colour of aerial mycelium was medium gray and 
colour of reverse side was brown. Diffusible pigments 
were not formed. It utilized glucose, L-arabinose, suc-
rose, xylose, inositol, mannitol and fructose. The analysis 
of cell wall hydrolysates showed the presence of LL-
diaminopimelic acid and glycine without any charac-
teristic sugar pattern. The taxonomic studies indicated 
that it belongs to the genus Streptomyces. A detailed 
survey of the literature indicated that it is closely related 
to Streptomyces albovinaceus. The comparison of our 
isolate with the reference culture established  that  it  is  a  

























variant of S. albovinaceus and was designated as S. 
albovinaceus var. baredar.  
 
 
Structure elucidation of compound 1 
 
The molecular formula of 1 was determined as C62H86N12 
O16 on the basis of the EI-MS (70eV), which gave a ([M
+], 
40) ion at m/z 1278.4; IRVmax (KBr) cm
-13400, 3250, 2950, 





H NMR spectrum of compound I in dimethyl-
sulfoxide (DMSO) with 300 MHz showed two ortho 
coupled protons at δH 7.66 and 6.73 of a 1,2,3,4-
tetrasubstituted aromatic  ring, and  two  3H singlets at δH 
2.02 and 1.95 of methyl groups in peri-position of an 
aromatic system. This is characteristic for the phenoxazi-
none chromophore (Figure 3) in various actinomycins.  
In addition, the spectrum showed overlapping NMR 
signals between δH 9.00-0.46 as it is indicative for two 
pentepeptide cyclic ring (α and β ring). Four broad 
doublet of amide proton at δH 8.97, 8.70, 8.18 and 7.66, 
twelve hydrogen signals of α-amino acid protons were 
observed at δH 6.40 (d), 6.27 (d), 5.16 (dd), 5.04 (m), 
4.61 (d), 4.41 (d), 4.14 (dd), 4.10 (dd) 2.87 (d) and 2.81 
(d), eight hydrogen signals of β-amino acid protons were 
observed at δH 5.81 (dq),  5.76 (dq),  3.40  (dd), 2.95 (m), 
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Table 1. Cultural characteristics of strain AUBN10 /2. 
 
Medium Growth Aerial mycelium Substrate mycelium Diffusible pigment 
 Yeast extract- malt extract agar (ISP2) Good Gray  Reddish brown None 
Oatmeal agar (ISP3) Poor Grayish white Yellowish brown None 
Inorganic salts-  starch agar (ISP 4)  Good Gray Brown None 
Glycerol asparagine agar (ISP 5) Good  Grayish white Reddish brown None 




Table 2. Cytotoxic activities of compound I. 
 
Cell line HMO2 Cell line HePG2 
GI50 TGI LC50 GI50 TGI LC50 
0.006 0.009 0.011 0.009 0.011 0.016 
 
All the concentrations are in µg/ml; GI50 = concentration which produces half of the maximum cell growth 
Inhibition; TGI = concentration which produces complete growth inhibition; LC50 = minimum concentration 












Figure 3.  Phenoxazinone chromophore. 
2.90 (dd), 2.77 (m), 2.58 (m) and 2.55 (m), twelve 
hydrogen signals of γ-amino acid protons were observed 
as ten doublet methyl proton at δH 1.66, 1.60, 1.58, 1.52, 
1.34, 1.32, 0.96, 0.94, 0.47 and 0.46 and two methylene 
proton at δH 1.92 and two hydrogen signals of δ-amino 
acid protons were observed as δH 4.05 (d) and 3.98 (d). 
The 
1
H NMR spectrum of compound I showed that four 
singlets methyl that were found at δH 2.75, 2.76, 2.06 and 
2.24, may be due to N-methyl groups (Table 4). The 
13
C 
NMR spectra exhibited 11 signals between δC 100 - 150 
and one at δC 178.6, which are attributed to the twelve 
ring-carbon atoms of the phenoxazinone system. Twelve 
carbonyls were observed around δC 165 - 175 and are 
characteristic   to  those  of  amide  and  lactone-carbonyl  






H NMR and 
13















Threonine C=O - 169.2 - 167.2 
CαH 5.04 55.9 5.16 55.5 
CβH 5.81 75.6 5.76 75.8 
CγH3 1.66 18.0 1.60 19.4 
NH 7.66 - 8.18 - 
Valine C=O - 167.8 - 169.7 
CαH 4.10 59.4 4.14 59.2 
CβH 2.55 32.6 2.58 32.3 
CγH3 1.52 21.9 1.32 19.6 
CγH3 1.58 19.4 1.34 18.9 
NH 8.97 - 8.70 - 
Proline C=O - 173.3 - 173.8 
CαH 6.27 57.1 6.40 56.9 
CβH 3.40 31.5 2.90 31.1 
CγH2 1.92 23.4 1.92 23.2 
CδH2 2.59 48.1 2.55 47.8 
Sarcosine C=O - 166.7 - 166.8 
CαH2 4.41, 2.87 51.1 4.61, 2.81 51.0 
N-CH3 2.76 34.6 2.75 34.6 
MethylValine C=O - 166.3 - 167.7 
CαH 2.37 71.1 2.48 71.3 
CβH 2.77 27.5 2.95 27.6 
CγH3 0.91 21.6 0.46 18.4 
CγH3 0.96 19.7 0.47 19.0 
N-CH3 2.06 38.8 2.24 38.8 
Phenoxazinone 
chromophore 
1 - 101.5 - - 
2 - 148.1 - - 
3 - 178.6 - - 
4 - 112.6 - - 
4a - 144.4 - - 
5a - 140.3 - - 
 6 - 126.8 - - 
7 6.75 129.7 - - 
8 7.65 125.9 - - 
9 - 129.2 - - 
9a - 132.9 - - 
10a - 146.3 - - 
4-CH3 1.95 7.4 - - 
6-CH3 2.02 14.5 - - 
1-CO - 173.3 - - 




groups of a peptide system. The α-carbon atoms of the 
amino acids are shown in the region (δC 50 - 72). In 
addition, two signals of oxygenated methine carbons are 
at δC 75 - 76. 
 The spectral information of the compound was search- 
ed in different databases like Chapman and Hall (2002), 
SciFinder, Beilstein and Antibase (Laatsch, 2000) and
 
hints were observed in the above databases. This 
indicated that compound I is a known compound which 
was earlier reported  from  terrestrial  actinos  (Eckardt  et  




al., 1970, 1972; Haupt and Eckardt, 1972; Hofle and 
Wolf, 1983) but not reported so far from marine sources 
(Figure 2). Our report can be considered as a new source 
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